Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients

Author(s):
Verboom, M.C.; Visser, L.; Kouwen, S.; Swen, J.J.; Diepstraten, J.; Posthuma, W.F.; Gelderblom, H.; Lammeren, D. van; Wilms, E.B.
Published
2017
Publication type
Article / Letter to editor
chronic myeloid leukemiaCYP2C8gastrointestinal stromal tumorimatinibpharmacogeneticspharmacokineticssingle nucleotide polymorphismtrough level
Date issued
2017-06-30
Language
English
Is part of
Pharmacogenetics and Genomics (2017), Vol. 27, no. 6, p. 223-226
hdl
1887/114731
doi
10.1097/FPC.0000000000000278